sympatico: primary analysis results of ibrutinib plus venetoclax for patients with r/r mcl
Published 10 months ago • 152 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
3:18
sympatico: safety and efficacy of ibrutinib plus venetoclax for r/r mcl
-
3:37
sympatico: ibrutinib combined with venetoclax in patients with r/r mcl
-
3:28
the sympatico trial: ibrutinib plus venetoclax in tp53-mutated mcl
-
1:23
interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll
-
3:07
ibrutinib venetoclax in treatment-naïve wm: results from a phase ii trial
-
8:42
my must-have products for sjogren's syndrome
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
5:41
primary results from the phase iii shine study: ibrutinib br for older patients with mcl
-
1:30
final results of the aim study of ibrutinib and venetoclax in mantle cell lymphoma
-
2:00
preliminary results of the aim trial of ibrutinib and venetoclax in mantle cell lymphoma
-
2:23
zilo-301: phase iii study of zilovertamab ibrutinib vs ibrutinib in r/r mcl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
1:30
oasis trial update: ibrutinib, venetoclax plus obinutuzumab in newly diagnosed mcl
-
2:24
interim analysis of the alpine study
-
2:45
optimizing the combination of ibrutinib plus venetoclax in cll
-
0:42
the limited access to novel therapeutics for sickle cell disease in lmics